Pfizer
Pfizer in advanced talks to buy cancer drug specialist Medivation for nearly $14 bn
22 Aug 2016
A successful deal would be Pfizer’s biggest acquisition since it purchased biologic drug specialist Hospira Inc last year for about $17 billion
Pfizer to buy Anacor Pharmaceuticals for $5.2 bn
16 May 2016
Pfizer blocks sale of lethal injections for executions
14 May 2016
Pfizer Inc, the largest US pharmaceutical company, yesterday said that it will block its drugs being used in lethal injections, effectively cutting off supply of the drug used by states for executions
Pfizer initiates buyout talks with cancer drug maker Medivation
04 May 2016
US drug giant Pfizer Inc has initiated talks with cancer drug maker Medivation Inc over a possible buyout, a move that could rival a $9.3-billion offer from Sanofi
Pfizer calls halt to $160bn merger with Allergan: report
06 Apr 2016
The decision comes after the US Treasury unveiled new rules that proposed to limit companies’ ability to participate in inversion transactions if they have been engaged in acquisitions within the past 36 months
New Treasury rules threaten Allergan-Pfizer merger
05 Apr 2016
The US Treasury Department has framed new rules to throttle ‘inversions’, in a move seen to be directly prompted by the proposed Allergan-Pfizer merger, which would create the world’s biggest drug firm
India bans Pfizer, Abbot cough syrups; shares tank
14 Mar 2016
The centre has banned Pfizer’s Corex and Abbot Laboratories’ Phensedyl after a panel of experts found the codeine-based drugs had ‘no therapeutic justification’ and were leading to addiction as well as smuggling
Allergen deal to help Pfizer save $35 bn in annual taxes: report
26 Feb 2016
The Pfizer-Allergen deal is the largest inversion ever, which would potentially lower the merged entity's annual tax bill by $35 billion in the United States
US politicians unite to flay Pfizer-Allergan deal
24 Nov 2015
Democratic presidential front-runner Hillary Clinton said the deal would “leave US taxpayers holding the bag”, while her Republican rival Donald Trump called it “disgusting”
Pfizer to take over Allergan in historic $150-bn deal
23 Nov 2015
The deal, the largest ever in the healthcare sector, will make Pfizer the world’s biggest drug maker, but the tax-cutting ‘inversion’ move is sure to draw political ire
Pfizer said to be in $150-bn merger talks with Allergan
19 Nov 2015
Merger talks are being held between US pharmaceutical giant Pfizer and Irish drug maker Allergan Plc, to create a global pharmaceutical behemoth worth over $300 billion
Pfizer, Allergan mull largest pharma merger
29 Oct 2015
US drug giant Pfizer Inc and Irish pharmaceutical company Allergan Plc are weighing a merger plan, which would create the world’s largest drug company with a market cap of more than $300 billion
Indian Patent Office rejects Pfizer's claim for arthritis drug patent
07 Sep 2015
The Indian Patent Office has rejected a patent application by pharma multinational Pfizer Inc for its rheumatoid arthritis drug `Tofacitinib’ for failing to prove its efficacy over its original version for which patent protection is ending
Pfizer is unnamed bidder for Swedish rare disease firm Orphan Biovitrum
02 May 2015
Pfizer’s interest in rare diseases first became evident in December 2009, when the company licensed the worldwide rights to taliglucerase alfa, a product that treats the genetic disorder Gaucher disease
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation